BACKGROUND To determine whether testing for DNA of oncogenic human papillomaviruses (HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we conducted a randomized trial comparing the two methods. METHODS We compared HPV testing, using an assay approved by the Food and Drug Administration, with conventional Pap testing as a screening method to identify high-grade cer...

BACKGROUND: CAP Pap test is a new test developed as an adjunct to routine PAP to improve its sensitivity. This test combines a simple biochemical test of enzyme labelling with conventional Pap Test in which abnormal squamous cells of the cervix are labelled for the presence of the Lysosomal enzyme, cervical acid phosphatase (CAP). Objectives: 1. To establish the sensitivity of new test CAP PAP ...

  Abstract   Background: Screening is a necessity for country health systems. In undeveloped   countries that have no screening programs, cervical carcinoma is one of the   major causes of mortality and morbidity. Although cervical cancer is preventable   it is poorly controlled in some countries. The main cause of it is unawareness of   people from cervical cancer and screening methods.   Meth...

BACKGROUND Despite the significant burden of cervical cancer, Malaysia like many middle-income countries relies on opportunistic cervical screening as opposed to a more organized population-based program. The aim of this study was to ascertain the effectiveness of a worksite screening initiative upon Papanicolaou smear test (Pap test) uptake among educated working women in Malaysia. METHODS 4...

OBJECTIVE To determine the sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results. DESIGN Population cohort study. SETTING Ontario. PARTICIPANTS Women between the ages of 18 and 70 years who were eligible for Papanicolaou testing. MAIN OUTCOME MEASURES Rates of cervical cancer screening and follow-up of abnormal and inadequate Pap test resul...

The aim of this study is to provide a profile of cervical cancer screening practices among the women in Patras and to assess factors associated with cervical cancer screening uptake. Data from a representative sample of 873 women were analyzed. 67.2% had at least one Pap test in their life, with 54.4% having been tested in the previous three years. Women aged 35-44 and 45-54 years were more lik...

BACKGROUND Cervical cancer, although usually preventable by Pap smear screening, remains the leading cause of cancer-related deaths among women in Peru. The percentages and characteristics of women in Peru who have or have not had a Pap smear have not been defined. METHODS In an urban community randomized trial of sexually transmitted infection (STI)/HIV prevention in Peru, 6712 randomly sele...

The Papanicolaou test (or Pap test) has long been used as a screening tool to detect cervical precancerous/cancerous lesions. However, studies on the use of this test to predict both the presence and change in size of genital warts are limited. We examined whether cervical Papanicolaou test results are associated with the size of the largest anal wart over time in HIV-infected women in an on-go...

Although little is known about the incidence of cervical cancer in women with intellectual disabilities (ID), Pap smear screening is an effective public health program to prevent cervical cancer to this group of people. The purposes of this study were to identify and evaluate the factors regarding the utilization of the Pap smears in women with ID seen in the preventive health screening program...

Background: Cervical cancer is the fourth leading cause of cancer death in women worldwide. Persistent infection with a high risk human papillomavirus (HR-HPV) is the main etiological factor, so that early early detection of HR-HPV is very important. The aim of this study was to investigate the efficacy of CareTM HPV, a new method, as compared with Pap smear, PCR, and biopsy for screening purpo...